Kellogg Cancer Care Center
Highland Park, Illinois, United States
Cancer treatment center in Highland Park, Illinois
777 Park Ave W, Highland Park, IL 60035
About Kellogg Cancer Care Center
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Clinical Trials at Kellogg Cancer Care Center
During the past decade, Kellogg Cancer Care Center conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 15 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 6 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
High-Dose Interferon Alfa in Treating Patients With Stage II or Stage III Melanoma
1998-12-01
2025-10-01
Active, not recruiting
1,150
S0221 Adjuvant Doxorubicin, Cyclophosphamide, and Paclitaxel in Treating Patients With Breast Cancer
2003-11-01
2027-01-01
Active, not recruiting
3,294
Pentostatin, Cyclophosphamide, and Rituximab Followed By Campath-1H in Patients With Relapsed or Refractory B-Cell CLL
2004-12-16
2018-05-06
Completed
102
Androgen Ablation Therapy With or Without Chemotherapy in Treating Patients With Metastatic Prostate Cancer
2006-07-28
2023-12-01
Active, not recruiting
790
Cetuximab, Cisplatin, Fluorouracil, and Radiation Therapy in Treating Patients With Anal Cancer
2007-01-01
2021-08-17
Completed
63
S0521, Combination Chemotherapy With or Without Gemtuzumab Followed By Tretinoin, Mercaptopurine, and Methotrexate or Observation in Treating Patients With Acute Promyelocytic Leukemia
2007-06-01
2016-05-04
Completed
105
Early or Delayed Fludarabine and Rituximab in Treating Patients With Previously Untreated Chronic Lymphocytic Leukemia
2008-01-01
2016-06-01
Terminated
84
S0535, Gemtuzumab and Combination Chemotherapy in Treating Patients With Previously Untreated Acute Promyelocytic Leukemia
2007-11-15
2018-02-05
Completed
78
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Kellogg Cancer Care Center"
#1 collaborator was "National Cancer Institute (NCI)" with 17 trials as a collaborator, "Cancer and Leukemia Group B" with 1 trials as a collaborator, "Children's Oncology Group" with 1 trials as a collaborator, "NCIC Clinical Trials Group" with 1 trials as a collaborator and "SWOG Cancer Research Network" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were
collaborators in the rest 5 trials.
Clinical Trials Conditions at Kellogg Cancer Care Center
According to Clinical.Site data, the most researched conditions in "Kellogg Cancer Care Center" are
"Leukemia" (5 trials), "Lymphoma" (3 trials), "Breast Cancer" (2 trials), "Lung Cancer" (2 trials) and "Anal Cancer" (1 trials). Many other conditions were trialed in "Kellogg Cancer Care Center" in a lesser frequency.
Clinical Trials Intervention Types at Kellogg Cancer Care Center
Most popular intervention types in "Kellogg Cancer Care Center" are "Drug" (14 trials), "Biological" (10 trials), "Radiation" (5 trials), "Other" (3 trials) and "Procedure" (1 trials). Other intervention types were less common.
The name of intervention was led by "cyclophosphamide" (5 trials), "rituximab" (4 trials), "doxorubicin hydrochloride" (3 trials), "methotrexate" (3 trials) and "cetuximab" (2 trials). Other intervention names were less common.
Clinical Trials Genders at Kellogg Cancer Care Center
The vast majority of trials in "Kellogg Cancer Care Center" are
16 trials for "All" genders and 1 trials for "Male" genders.
Clinical Trials Status at Kellogg Cancer Care Center
Currently, there are NaN active trials in "Kellogg Cancer Care Center".
undefined are not yet recruiting,
undefined are recruiting,
4 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 11 completed trials in Kellogg Cancer Care Center,
undefined suspended trials,
and 1 terminated clinical trials to date.
Out of the total trials that were conducted in Kellogg Cancer Care Center, 0 "Phase 1"
clinical trials were conducted, 9 "Phase 2" clinical
trials and 6 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 1 trials that are defined as “Not Applicable".